Welcome Guest
Sign In
Register
Home
Bioprocessing
Chromatography
Drug Delivery
Excipients
Formulation Development
Microbiology
Spectroscopy
Articles
Issue Archives
Whitepapers / App Notes / eBooks
Industry Expert
Facility Tour
CGT Circuit
News
Products
Featured Products
New Products
Analytical Equipment
Formulation Development
Pharmaceutical Manufacturing
Excipients
All Other Products
QC Corner
Webinars
Videos
A Solid Dosage Future Documentary
Clean Facility Documentary
Continuous Processing Documentary
Cell and Gene Therapy Documentary
Making Data Work Documentary
Company Profiles
Events
Register
Sign In
Home
Microbiology
Product Center
Formulation Development
Pharmaceutical Drug Delivery Technologies
Pharmaceutical Drug Delivery Technologies
Pharmaceutical drug delivery technologies enhance drug absorption, efficacy, and patient experience. Various types of dosage forms can be used to alter and enhance drug delivery. Common drug delivery forms are parenterals dosage forms, solid dosage forms such as capsules and pressed tables and various liquid dosage forms.
Dosage forms can include taste maskers to increase the commercial viability of your pharmaceutical products by neutralizing the strong, bitter tastes of certain oral medical formulations.
Enhancing the drug delivery technology of your final pharmaceutical formulation can increase its commercial success.
Showing 30 of 40 products
<<
<
1
2
>
>>
Sort By
- select -
Item Name
Company Name
Price
Get quotes for all products
Select All
Select up to 5 products from below to compare or request more information.
Compare
Acconon C-44 EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Permeation Enhancement; Solubilization; Emulsification; Encapsulation
Get quote
Compare
or
Get quote
for selected.
Acconon C-50 EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal; Opthalmic
Pharmaceutical Application:
Solubilization; Emulsification; Encapsulation
Get quote
Compare
or
Get quote
for selected.
Acconon MC8-2 EP/NF
ABITEC
Type:
Inquire
Pharmaceutical Application:
Solubilization; Emulsification; Encapsulation
Get quote
Compare
or
Get quote
for selected.
Acconon® AKG-6 EP/NP
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
BBS-C
ABITEC
Type:
Inquire
Dosage Form:
Oral; Suppositories
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Capmul GDB EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral
Pharmaceutical Application:
Lubrication
Get quote
Compare
or
Get quote
for selected.
Capmul GMO-50 EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul INJ MCM EP
ABITEC
Type:
Inquire
Dosage Form:
Parenteral
Pharmaceutical Application:
Solubilization
Get quote
Compare
or
Get quote
for selected.
Capmul MCM C8 EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Permeation Enhancement; Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul MCM EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Opthalmic
Pharmaceutical Application:
Permeation Enhancement; Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul MCM NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal; Opthalmic
Pharmaceutical Application:
Permeation Enhancement; Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul PG-12 EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Permeation Enhancement; Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul PG-2L EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral
Pharmaceutical Application:
Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul PG-8 NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul PG-8-70 NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Capmul® 808G EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Permeation Enhancement; Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Caprol® PGE 860
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal
Pharmaceutical Application:
Solubilization; Emulsification
Get quote
Compare
or
Get quote
for selected.
Captex 200P
ABITEC
Type:
Topical & Transdermal
Dosage Form:
Inquire
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Captex 300 EP/NF
ABITEC
Type:
Inquire
Dosage Form:
Liquid
Pharmaceutical Application:
Solubilization; Lubrication
Get quote
Compare
or
Get quote
for selected.
Captex 355 EP/NF/JPE
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal; Opthalmic
Pharmaceutical Application:
Solubilization; Lubrication
Get quote
Compare
or
Get quote
for selected.
Captex 8000
ABITEC
Type:
Inquire
Dosage Form:
Oral; Topical & Transdermal; Opthalmic
Pharmaceutical Application:
Solubilization
Get quote
Compare
or
Get quote
for selected.
Captex INJ 300 Low C6 EP/ NF/JPE
ABITEC
Type:
Inquire
Dosage Form:
Parenteral
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Captex INJ 355 EP/NF/JPE
ABITEC
Type:
Inquire
Dosage Form:
Parenteral
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Captex INJ 8000
ABITEC
Type:
Inquire
Dosage Form:
Parenteral
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Captex® 170 EP
ABITEC
Type:
Inquire
Pharmaceutical Application:
Solubilization
Get quote
Compare
or
Get quote
for selected.
Hyrdo~Kote 112
ABITEC
Type:
Inquire
Dosage Form:
Topical & Transdermal; Suppositories
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Hyrdo~Kote M
ABITEC
Type:
Inquire
Dosage Form:
Topical & Transdermal; Suppositories
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Hyrdo~Kote® C
ABITEC
Type:
Inquire
Dosage Form:
Topical & Transdermal; Suppositories
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Pureco 76
ABITEC
Type:
Inquire
Pharmaceutical Application:
Inquire
Get quote
Compare
or
Get quote
for selected.
Sterotex K, NF
ABITEC
Type:
Inquire
Dosage Form:
Oral; Suppositories
Pharmaceutical Application:
Encapsulation; Lubrication
Get quote
Compare
or
Get quote
for selected.
Select All
Select up to 5 products from above to compare or request more information.
Compare
Showing 30 of 40 products
<<
<
1
2
>
>>
Tags:
Please Login or Register to Create Tags
Feedback
Articles
MEDMIX Systems AG Announces Twin-Syringe Biomaterial Delivery System with Low Pressure Air-Assisted Spray Nozzle and Laparoscopic Tip
IntelGenx Announces Commencement of Pivotal Clinical Trial
Mayor Lane and West Pharmaceutical Services to Host Community Groups, Local Dignitaries at Scottsdale Facility Ribbon-Cutting
Latest Developments in Injectable Drug Delivery
Metal Leachables in Therapeutic Biologic Products: Origin, Impact and Detection
Celanese Invites Pharmaceutical Industry to Participate in Discussion on the Topic of EVA Polymers and Drug Delivery
Recent Developments in Prefilled Syringes
Lilly to Expand Indianapolis Insulin Manufacturing Operations
Implementing Nanotechnology and Novel Drug Delivery Systems to Improve Dissolution and Solubilization
Observations on Nanotechnology-based Drug Delivery Approaches: Translating Nanotechnology from Bench to Pharmaceutical Market: Barriers, Success, and Promises
BD Completes Acquisition of Safety Syringes, Inc.
SPI Pharma Announces Actimask Ibuprofen
New appointment extends Freeman Technology’s applications team
Key Industry Experts Share Their Insights on How Inhalation Drug Delivery Systems Are Gathering Momentum
Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective
Extractables and Leachables: Quality Concerns and Considerations for Ophthalmic and Injectable Products
CE 7 Smart Apparatus 4 for Flow-Through Cell Dissolution
AT 70 Smart Dissolution Testing Equipment
Towards an Understanding of Nanostructures Formed during Digestion, and their Impact on Drug Delivery and Absorption
Advances in Lipid-based Formulations: Overcoming the Challenge of Low Bioavailability for Poorly Water Soluble Drug Compounds
Oral Lipid-Based Drug Delivery Solutions to Meet Complex Bioavailability Challenges Presented by Two Global Catalent Experts at AAPS Workshop
Mayne Pharma Usa Acquires Branded Products
Actimask® Acetaminophen 92M
Mitigating Risks Associated with Aseptic Parenteral Filling
Integrity Applications Signs Distribution Agreement for GlucoTrack
Amgen Receives Positive CHMP Opinion for Neulasta Delivery System
FDA approves Toujeo Max SoloStar
3M Drug Delivery Systems to Enhance Manufacturing Capabilities
Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran
AstraZeneca and The Medicines Company Announce Global Collaboration in Acute Ischemic Heart Disease
Drug Solubilization Strategies Applying Nanoparticulate Formulation and Solid Dispersion Approaches in Drug Development
Gaining Knowledge on Drug Absorption: Gathering Physicochemical Data for PK Simulations
Use of Enzymes in the Dissolution Testing of Gelatin Capsules
West Pharmaceutical Services to Share Insights and Showcase Solutions for Drug Delivery, Safety and Efficacy at PDA Conference and AAPS Annual Meeting
Interview with Catalent-Introducing the Applied Drug Delivery Institute
Aptalis Pharmaceutical Technologies Announces European Commission Approval for a New Oral Granule Formulation of Viread®
Catalent and Aegerion Partner on Launch of Newly FDA Approved Juxtapid™
Aptalis Pharmaceutical Technologies Expands Licensing Team
Capsugel Announces Acquisition of Encap Drug Delivery
Malvern and Next Breath workshop at RDD 2013 links dissolution and particle size via Raman imaging
ATCC Universal Mycoplasma Detection Kit
Aptalis Pharmaceutical Technologies Co-Sponsors 2013 Controlled Release Society's Young Investigator Award at 40th Annual Meeting and Exposition
2013 AAPS Election Results Announced
Exscientia, GSK Enter into Drug Discovery Collaboration
Approaches for Dissolution Testing of Novel Drug Delivery Systems
Extractable and Leachable Implications on Biological Products in Prefilled Syringes
708-DS Dissolution Apparatus
Haselmeier Establishes New Pen Injector Assembly Facility in India
Hospira Receives FDA Clearance for Symbiq™ 3.13 Infusion Pump
At INTERPHEX NYC, Pharma Technology Inc. to Debut Enhanced Tablet Tester for PharmaFlex AIO Deduster System
An Interview With Jasmine Musakhanian, M.Sc. Marketing & Scientific Director of Pharmaceutical Division Gattefossé USA
Diffucaps Customized Release Technology
Evox to Collaborate with Boehringer Ingelheim on Exosome-Mediated Drug Delivery
Fresenius Kabi Introduces Bortezomib for Injection
Phase 1 Clinical Trial for Hantavirus Vaccines Yields Positive Interim Results
Vaccibody Moving Forward with Cancer Neoantigen Vaccine Trial
DSM signs Master Supply Agreement with Eisai Inc.
West Celebrates 90 Years of Healthcare Innovation
Recipharm and Synthonics Join Forces to Promote Novel Drug Delivery Technology
Controlled Release Pulmonary Therapies: Promises and Concerns
va-Q-tec Passive Pallet Containers Approved For Transport On United Airlines
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies
Apricus Biosciences Receives Notice of Issuance for First Prevonco(TM) Patent in the United States
Enablement of Accurate Dose Administration for a Pre-Filled Syringe Drug Product
Controlling Release from Dosage Forms: The Future
Plastic Pre-fillable Syringes and Vials: Progress Towards a Wider Acceptance
Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co. Ltd. and Extensive Investments to it's Zydis® to Technology Capabilities in Swindon, UK
Capsugel Announces Expansion of its Executive Leadership Team
Drug Product Development Processes for Lipid-based Drug Delivery Systems
Study Illustrates Morphologi G3-ID Application for Inhaled Product Characterization
Aptalis Pharma U.S., Inc. Announces U.S. Commercial Availability of ULTRESA(TM) (Pancrelipase) Delayed-Release Capsules
Gerresheimer Acquires Indian Pharma Plastic Packaging Manufacturer Triveni
Mallinckrodt Announces Approval of New Gablofen® Prefilled Syringe
NanoSmart Pharmaceuticals Receives Drug Delivery Partnerships' 2013 “On the Rise” Award
Strategies to Formulate Lipid-based Drug Delivery Systems
Amorphous Solid Dispersions as Enabling Formulations for Discovery and Early Development
709-DS Dissolution Apparatus
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing
Determining Drug Release From Compritol® 888 Atomatrix Formulations
Prescient Surgical Receives FDA 510(k) Clearance for CleanCision
Vaccibody Expands Human Clinical Trial of HPV Vaccine
AOBiome Reports Positive Clinical Safety Results for Microbiome-Targeted Therapy for Intranasal Delivery
Mission and EffRx Bring New Osteoporosis Medication
LUCASSIN® Approved in Australia
Repligen Reports Positive Results From Phase 1 Clinical Trial for Spinal Muscular Atrophy (SMA)
Application of Electrostatic Layer-by-Layer Nanocoating in Drug Delivery
Aptalis Pharmaceutical Technologies Sponsors 2012 Controlled Release Society’s Young Investigator Award at Annual Meeting and Exposition
BD Announces Agreement to Acquire Safety Syringes, Inc.
Quality by Design (QbD) of Sterile Dosage Form Packaging
Ei Gains Exclusive World-Wide License for Sphingolipid
Developing Better Medicines for Children: Addressing International Priorities
Catalent to Supply the Newly Approved Exelixis COMETRIQ™ (CaBOZANTINIB) in the US Market
Catalent Pharma Solutions Announces Launch of Catalent Applied Drug Delivery Institute
OsoBio to Join Injectable Trends Discussion at DCAT Week
West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
Catalent Applied Drug Delivery Institute Welcomes Accomplished Life Sciences Leader Dr. Ralph Lipp to Advisory Board and Terry Robinson as Executive Director
Unilife Develops Unifill Assure™ to Enhance Patient Self-Injection of Biologics
Mallinckrodt New Drug Application Granted Priority Review by FDA
Application Challenges and Examples of New Excipients in Advanced Drug Delivery Systems
Drug Delivery Roundtable
Future Materials for Prefilled Syringe Components
Challenges in the Development of Pre-filled Syringes for Biologics from a Formulation Scientist’s Point of View
CFS 1200 Liquid Filling and Sealing Machine
The Truths and Myths of Oral Lipid-Based Drug Delivery Systems
FDA Approves Lucentis 0.3 mg Prefilled Syringe
JDRF Awards International Diabetes Center Grant to Investigate the Use of Intranasal Insulin Delivery
Hovione files its first Investigational New Drug Application with the FDA
Polymer Strip Films for Delivery of Poorly Water-Soluble Drugs
leading INDUSTRY & acadEMIC EXPERTS TO Discuss Drug Delivery Technologies to Overcome Bioavailability Issues at basel Symposium
Freeman Technology Md Presents ‘measuring and Understanding Powder Flow’ at Mixing Consultants Workshop
Future of Transdermal Drug Delivery Systems (TDDS)
Pharmaceutical P.I.N. Points Patent Innovation News
The Lifecycle of Drugs from Development to Approval and Market Launch
FDA Accepts Xcovery’s NDA for Ensartinib
Tackling Complex Generics: Analytical Techniques to Support the Deformulation and Development of Orally Inhaled Products
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
Track and Trace
Antibody-Drug Conjugate Roundtable
Bringing Poorly Soluble Molecules to Market with Bioavailability Enhancement Technologies
Roundtable
Advancing Solid Dose Processing Efficiency and Effectiveness
Defining the ‘Dose’ for Dry Powder Inhalers: The Challenge of Correlating
In-Vitro
Dose Delivery Results with Clinical Efficacy
Haselmeier Announces the CE Mark for JuniorSTAR
®
Half-Unit Insulin Pen
Hovione: New Inhalation Capsule Filling Machine Fills Market Gap
Haselmeier Announces the Extension of its Business Development Organization within the Haselmeier Group
Drug Delivery Roundtable
Supply Chain Management and the Importance of Security of Supply
Global pharmaceutical supply chain trends Q4 2016
Speed-to-Market: Process and Capacity on Demand
New Strategies Required to Meet Changing Needs in the Analytical Services Market
Formulating Amorphous Solid Dispersions: Bridging Particle Engineering and Formulation
Drug Nanocrystal Technologies for Oral Drug Delivery
A New Risk Assessment Tool for Regulatory Starting Material Evaluation
Supporting the Pharma Industry Small Business Growth Engine
Dissolving Boundaries In Worldwide Clinical Trial Logistics for Biological Samples and New Therapies
Why Consider a Lipid-Based Drug Delivery System (LBDDS)?
Article: Addressing Challenges with Clinical In-Use Testing of Biotherapeutics
Pharma Technology Inc. Introduces Core Coating Module for Roeltgen’s FlexiTab® Tablet Press
3M Scotchpak White Backings and Release Liners Bring Greater Visibility for Transdermal and Dermal Drug Delivery Systems
Why Innovative Drug Delivery Packaging Solutions are needed for Today’s Patients
CSafe and BioLife Solutions Partner on Supply Chain Solutions for Cell and Gene Therapies
Solubility in Pharmaceutical R&D: Predictions and Reality
AmerisourceBergen Enhances Global Market Position through European Acquisition
Micromeritics and ETH Zurich Presenting Advanced Porous Materials Workshop, June 2 – 3
USPTO Grants a New Inhaler Patent to Hovione
Controlled Onset Oral Drug Delivery: An Opportunity for Innovative Life Cycle Management
An Interview With T.N. Thompson (President, Millrock Technology, Inc.)
Meeting Unmet Patient Needs withSmall-Volume APIs
Roundtable
Perspectives on Product Pricing Strategy and Practice
Transforming The Pharmaceutical Industry Pipeline with In Silico Approaches
Performance Testing for Topical and Transdermal Drug Delivery
Orally Disintegrating Tablets: A Dosage Form Designed for Difficult Patient Populations
An Interview With... Sam Herbert, President, World Courier
Catalent Pharma Solutions Participates in Inaugural Blackstone Veterans Hiring Summit
Bend Research Improves Speed-to-Clinic Capability for Oral and Inhalation Formulation Development
Expert Presentations at Australia Workshop on Powder Characterisation and Inhaler Testing
Review of Dry Powder Inhaler Devices
Enabling Right-First-TimeTech Transfer with Effective Scale-down Modeling
From Qualified to Ideal: The Importance of Partnership
ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
Improving the Bio-Availability of Drugs Through Their Chemistry
Future Pharma Partner Models - Unique Delivery & Design
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Microneedles Breakthrough Brings 3M One Step Closer to Introducing New Alternative Drug Delivery Method
Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New Adhd Treatments
Catalent Announces Two Senior Appointments to Expand Biologics Business
Rain Therapeutics and Roche to Collaborate on Clinical Trial of Milademetan Combination with Anti-PD-L1 Immunotherapy for Various Solid Tumor Indications
Nice Insight: 2017 Industry Leaders
Capsugel Receives Verification from the Non-GMO Project for Its Vcaps
®
Plus and Plantcaps™ Capsules
Bend Research To Highlight Latest Drug Formulation Technologies
West Completes Preliminary Study Evaluating the SmartDose Electronic Patch Injector Technology Platform, Which Incorporates a Daikyo Crystal Zenith Cartridge
Pharmacyclics and Catalent Solidify Partnership on the Recently Approved Oncology Therapy, IMBRUVICA™
Orphan Drug Model to be Debated by Catalent Expert at FDA/CMS Summit
Recipharm Subsidiary Files Infectious Disease Drug Application in European Markets
3rd Annual Global Academic Competition For Life Sciences Leaders Of Tomorrow
Patient-Centered Drug Delivery Innovation
A Tale of Two Drug Delivery Strategies: Simple Solubilization or Sophisticated Supersaturation?
Dose and Form Matter: Future of Care Demands Optimal Drug Delivery
Quality Culture Wins Over Compliance
FDA’s Regulatory Science Program for Generic PLA/ PLGA-Based Drug Products
Advances in Purification Technologies Accelerate Vaccine Development
Designing Effective Drug Formulations: Keys to Successful Proof of Concept Services
A Look At Recent Pharma Industry Innovations
Think Tank Forum
Achieving Successful Treat ment Outcomes through the Delivery of Manufacturing Services
Drug Delivery Roundtable
Controlling the Stability of Medicinal Suspensions
Hydroxypropyl Cellulose for Orally Disintegrating Film Drug Application
Pharmaceutical P.I.N. Points: Patent Innovation News Jan/Feb 2024
Lipid Nanoparticles – The Enablers for Nucleic Acids Delivery
Nanoparticle Technologies: Enablers for Ocular Drug Delivery
Drug-Excipient Compatibility for the Formulation Development of Solid Lipid Nanoparticles
An Interview With... Aileen Ruff VP, Business Unit Strategy and Marketing, Drug Delivery Solutions, Catalent
Gerresheimer Extends Medical Devices Operations in the US
Pure MHC and Catalent Sign RL21 Anti-cancer Development Deal
American Association of Pharmaceutical Scientists Launches Foundation
OsoBio Reaffirms DCAT Partnership Through New Leadership Positions
SPI Pharma Launches Pharmaburst
®
500 Microsite
Innovative Abuse-Deterrent Opioid Medications
Integrating Drug Discovery and Development to Improve Efficiency & Candidate Success
Innovation at the Heart of Biopharmaceutical Industry Growth
Controlled Release Technologies and Trends
Changes In the Wind for the CDMO Market
There Is Almost No Aspect of the Life Sciences and Related Industries That Big Data Cannot Impact.
Pharma’s Reputation Gap: Consumer Business Innovation
Capsugel’s Transformation
Advancing Patient-Centric Parenteral Drug Strategies
Two Promising Small- Molecule Orphan Drugs In Clinical Trials
Finding The Ideal Partner For Your Next Biotherapeutic
Patient-Centric Drug Development: Designing Medicines to Succeed
Future Pharma Partner Models - Effective Drug Delivery
Endo to Acquire Specialty Generics Company Boca Pharmacal
Catalent Pharma Solutions and Supernus Partner for Supply of Trokendi XR™
Capsugel’s Scintigraphic In Vivo Study of DRcaps™ Capsules Visually Tracks Successful Delayed Release of Ingredients
Major Advances in Oral Drug Delivery over the Past 15 Years
Specialists from Malvern Instruments Present New Ways of Accelerating Development of DPI formulations
Predicting and Selecting Formulations for Drug Discovery and Early Development
Trends in Demand for Various Excipients
Curia Appoints New Manufacturing Lead
Logan Instrument Launches to International Markets
Applied BioMath Presents Quantitative Systems Pharmacology Model of Lipid Nanoparticle mRNA Delivery
Case Study: Application of Captisol® Technology to Enable the Formulation of Remdesivir in Treating COVID-19
Finding a Greater Vantage Point for Creating Green Therapies
Keeping Patients in Focus: Limiting Treatment Burden for Improved Eye Care
The Trials and Tribulations of Pharmaceutical IP Management
Spending on Contract Research Services Slowing Down
Future Pharma Partner Models - Outsourcing Trends in API Development & Manufacturing
Facilitating Tech Transfer For Parenteral Products
AstraZeneca’s Andexxa Phase IV Trial Ends Early After Achieving Pre-Specified Criteria
Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States
Chiesi Farmaceutici and Cornerstone Therapeutics Announce Agreement for a Merger Transaction in Which Chiesi Will Acquire 100 Percent Ownership of Cornerstone for $9.50 per Share in Cash
Catalent Acquires Relthy to Expand South American Softgel Technologies Business
Cindy Kent Named President and General Manager of 3M Drug Delivery Systems
Stretching the Limits of Dry Powder Pulmonary Drug Delivery
Ratio Therapeutics Appoints Dr. Noel Monks as Head of Biology
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
Noramco, SPI Pharma Announce Availability of Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms
AMETEK Completes Acquisition of Paragon Medical
Bayer Strengthens Drug Discovery Platform Through Acquisition of Vividion Therapeutics
Challenges and Opportunities in Developing Up-to-Date USP–NF Excipient Monographs
Improving the Performance of Lipid Formulations: Nanoparticle Layers and Solid Hybrid Particles
Unilife Signs Long-Term Supply Contract with Sanofi for the Use of Unifill® Syringes with Lovenox®
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC
Federal Court Enters Consent Decree Against Oklahoma Drug Compounder
Cryoport Confirms No Financial Exposure to Silicon Valley Bank
FDA Publishes Draft Guidance on Quality Considerations for Topical Ophthalmic Drug Products
AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity
Roche Completes $7.1B Acquisition of Telavant from Roivant
Cholesgen and AstraZeneca Partner to Develop Hypercholesterolemia Treatments
Caris Life Sciences Partner with Merck to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
Pharmaceutical P.I.N. Points: Patent Innovation News
FDA Clears Biomea Fusion’s IND Application for Leukemia
Pharmaceutical P.I.N. Points Patent Innovation News
Equipment Must Integrate
Nanopreparations for Delivery of Non-Deliverable Pharmaceuticals
Catalent Applied Drug Delivery Institute Appoints Professor Claus-Michael Lehr to Advisory Board
Key Targeting Approaches for Pharmaceutical Drug Delivery
Quality by Design: Transforming 21st Century Pharmaceutical Manufacturing
The Effect of FTC Challenges to Pay-For- Delay Agreements: Brand-Name and Generic Companies Abandon Large Cash Payments and Other Forms of Reverse Payments
HIV Drugs Market Size Is Set to Grow by USD 10.47 Billion From 2023-2027
FDA Adds Quinacrine HCL to Bulk Drug Substances List to Be Used in Compounding by Outsourcing Facilities
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
Blended Natural Language Processing Solutions Combine Best of LLM and Deterministic Approaches to Improve Drug Development
UPMC and PharmaLogic Partner to Develop Radiopharmaceuticals
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
Drug Delivery Roundtable
Innoviva to Acquire Entasis Therapeutics
Lannett Receives FDA Approval to Manufacture Numbrino® at Seymour Plant
AstraZeneca Completes Acquisition of CinCor Pharma
Bayer and Thermo Fisher Scientific Collaborate to Increase Patient Access to Precision Cancer Medicines
Should Drug-Delivery Device Patents be Listed in the Orange Book?
Takeda to Collaborate with JCR Pharmaceuticals on Next-Gen Hunter Syndrome Treatment
Lonza Launches AI-Enabled Route Scouting Service to Accelerate Small Molecule Development
MannKind Receives FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial Lung Disease
Your Nails and You
Hovione and Laxxon Medical Establish an Agreement for cGMP Production of 3D Screen Printed Pharma Applications
Capsugel to Acquire Bend Research
Choosing the Optimal Drug Delivery System to Meet Patient Needs
Growth Anticipated for Intermediates
Gerresheimer Invests Up to $94M in US Production |
Still Early Days for AI in Drug Discovery… Says Who?
Addex and Perceptive Launch Neurosterix to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain Candidate
XtalPi and Parthenon Enter Into AI-Powered Antibody Discovery Partnership
Whitepaper: VOC Reducing Additives for Masterbatches and Final Polymer Articles
FDA Approves QULIPTA for Adults with Chronic Migraine
Pharmaceutical P.I.N. Points Patent Innovation News
Premier Research Adds to Cell and Gene Therapy Leadership Team
FDA Approves Novartis’ Fabhalta as the First Oral Monotherapy for Adults with PNH
The Role of Lipids in Mitigation of Food Effect
Rilzabrutinib LUNA 3 Phase 3 Study Met Primary Endpoint in Immune Thrombocytopenia
A New Look for BRANDTECH Scientific
FDA Broadens Indication for Verzenio® in High-Risk Early Breast Cancer
ANI Pharmaceuticals Announces FDA Approval and Launch of Rifabutin Capsules USP
Application of QbD Principles to the Scale-Up of a Nasal Suspension Drug Product
Achieving Continuous Downstream Bioprocessing
Key Considerations for Stabilizing Oxidation-Prone Lipid-Based Drug Delivery Systems
Raw Materials/ Functional Excipients Roundtable
Pre-Fillable Syringes: Considerations to Enhance the Patient Experience
US WorldMeds Announces FDA Approval of IWILFIN™ to Treat Aggressive Childhood Cancer
VIVAPUR® MCG - a Powerful Stabilizer for Nasal Sprays
Novartis Receives CHMP Positive Opinion for Enerzair® Breezhaler
Unleashing the Potential of AI: Revolutionizing Rare Disease Research and Drug Development Through Diversity and Innovation
Accelerating Approval and Reducing Costs of Spray Dried Drugs through Development by Design (DbD)
Fluidity Versus Certainty in Early Small Molecule CMC Development
Almirall and Absci Announce AI Drug Discovery Partnership for Derm Diseases
Whitepaper: The Relevance of Polymorph Screening in the Pharmaceutical Industry
Controlled Release Roundtable
Enhancing Formulation Development: Leveraging Specialty Chemicals for Improved Drug Delivery
Apalutamide Study Demonstrates the Advantages of Nanoforming for Cancer Treatment Formulations
Hyloris Announces FDA Approval of Maxigesic IV
Pharmaceutical P.I.N. Points Patent Innovation News
Pre-filled Syringes for Safe and Accurate Drug Delivery
Endogenous Mechanisms for Nanoparticle-Based Nucleic Acid Delivery
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »
Featured Products
Pearlitol 200SD
FlowLac® 90
Klucel™ exf ultra hpc
Connect with Us